In a significant effort to find alternative treatments for head and neck cancer patients who cannot use cisplatin due to its harmful side effects, researchers conducted a new clinical trial that unfortunately provided discouraging results. Cisplatin is a widely used chemotherapy drug known for its
Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. Can you tell us a little about your professional background and your role as a biopharma expert? Certainly. I have spent the last couple of decades working at
Laboratory research has always been at the forefront of scientific innovation, driving breakthroughs in medicine, materials science, and more. Recently, the integration of automation and artificial intelligence (AI) has begun to revolutionize how research is conducted, offering unprecedented
Cancer biology has traditionally emphasized the competitive nature of tumor cells as they compete fiercely for limited resources. However, recent research led by Carlos Carmona-Fontaine at New York University has unveiled a groundbreaking and surprising discovery that cancer cells also exhibit
The intersection of biotechnology and artificial intelligence (AI) is poised to address the inefficiencies and ethical concerns plaguing the current drug development process. One of the most promising innovations in this field is the Bio-AI clinical prediction platform developed by Quris-AI, which
Cancer therapy has always been a challenging field, with the need to balance efficacy and minimize side effects. Traditional treatments often lack precision, leading to systemic toxicity and reduced patient quality of life. In recent years, the development of drug-based nanostructures has emerged
